|
시장보고서
상품코드
2038947
니파바이러스 감염증 시장 : 제품 유형별, 검사 유형별, 기술 플랫폼별, 검체 유형별, 최종사용자별, 지역별Nipah Virus Infection Market, By Product Type, By Test Type, By Technology Platform, By Sample Type, By End User, By Geography |
||||||
니파바이러스 감염증 시장은 2026년에 5,480만 달러로 추계되고 있으며, 2033년까지 1억 2,360만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 12.32%로 성장할 것으로 전망되고 있습니다.
| 리포트 범위 | 리포트 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 5,480만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 2026-2033년 예측 기간의 CAGR : | 12.32% | 2033년 시장 규모 예측 : | 1억 2,360만 달러 |
세계의 니파바이러스 감염증 시장은 최근 수년간 확인된 가장 심각한 감염 질환 중 하나를 대상으로 하는 감염병 관리 분야의 중요한 분야입니다.
1998년 말레이시아에서 발생한 유행 당시 처음 확인된 니파바이러스 감염증은 파라믹소바이러스의 일종으로 감염된 사람에게 심각한 뇌염과 호흡기 질환을 유발하며 치사율은 40%에서 75%에 달합니다. 이 질병은 감염된 과일박쥐에서 돼지 등의 중간숙주를 통해 또는 감염된 박쥐의 분비물과의 직접 접촉을 통해 사람에게 감염되며, 방글라데시, 인도, 동남아시아 등의 유행국가에서 공중보건상 심각한 문제가 되고 있습니다.
이 바이러스는 팬데믹을 일으킬 가능성이 높고, WHO에서 우선순위 병원체로 지정되어 시장의 큰 주목을 받고 있으며, 연구개발의 필요성이 강조되고 있습니다. 인수공통전염병 발생률의 증가와 더불어 바이오 보안 위협에 대한 인식이 높아지고 감시체계가 강화되면서 제약기업, 생명공학기업, 공중보건기관의 지속적인 투자가 촉진되고 있으며, 니파바이러스 감염증 분야에서 혁신적인 시장 환경이 형성되고 있습니다.
시장 역학
니파바이러스 감염증 세계 시장은 인수공통전염병 발생률의 증가, 전 세계가 전염병 대응에 집중하고 있으며, 신흥 전염병에 대한 정부 및 국제적인 자금 지원의 증가에 영향을 받고 있습니다. WHO가 니파바이러스를 우선순위 병원체로 분류한 것과 니파바이러스 백신 개발을 위한 '감염병 대책 혁신 연합(CEPI)' 등의 단체의 자금 지원 증가가 시장 성장을 촉진하고 있습니다.
또한 전염병이 유행하는 지역의 도시화와 삼림 벌채의 가속화도 시장을 주도하고 있습니다. 이는 동물과 인간의 접촉 기회가 증가함에 따라 감염 확산의 위험이 높아졌기 때문입니다. 또한 분자진단 시장의 기술 발전, 특히 실시간 PCR과 차세대 시퀀싱 기술의 발전도 시장을 촉진하고 있습니다.
그러나 시장에는 심각한 제약도 존재합니다. 특히 감염이 산발적이고 국소적인 특성으로 인해 제약 시장에서의 투자 기회에 대한 상업적 관심도가 낮다는 점을 꼽을 수 있습니다. 백신 및 의약품의 높은 개발 비용과 더불어 임상 시험 수행의 어려움은 시장에 심각한 제약으로 작용하고 있습니다. 또한 특히 전염병이 유행하는 지역의 의료 인프라 부족도 시장에 심각한 제약이 되고 있습니다.
시장에는 큰 제약 요인이 존재하는 반면, 파트너십과 공동연구의 기회도 크게 확대되고 있습니다. 또한 바이오 보안의 동향은 중요하며, 특히 '원헬스'와 신속한 백신 개발 기술의 활용을 통해 향후 시장 가능성에 긍정적인 영향을 미칠 것으로 예상됩니다.
본 조사의 주요 특징
- 이 보고서는 각 부문의 잠재적 매출기회를 파악하고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수(회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략)를 기반으로 전 세계 니파바이러스 감염증 시장의 주요 업체를 프로파일링합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계의 니파바이러스 감염증 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 글로벌 니파바이러스 감염증 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 니파바이러스 감염증 시장 : 제품 유형별, 2021-2033년
제5장 세계의 니파바이러스 감염증 시장 : 검사 유형별, 2021-2033년
제6장 세계의 니파바이러스 감염증 시장 : 기술 플랫폼별, 2021-2033년
제7장 세계의 니파바이러스 감염증 시장 : 검체 유형별, 2021-2033년
제8장 세계의 니파바이러스 감염증 시장 : 최종사용자별, 2021-2033년
제9장 세계의 니파바이러스 감염증 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 추천
제12장 참고 문헌 및 조사 방법
KSA 26.06.02Nipah Virus Infection Market is estimated to be valued at USD 54.8 Mn in 2026 and is expected to reach USD 123.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 12.32% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 54.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 12.32% | 2033 Value Projection: | USD 123.6 Mn |
The global Nipah virus infection market is an important segment in the infectious disease management domain, which targets one of the most critical infectious diseases identified in recent times.
Nipah virus infection, first identified during an epidemic in Malaysia in 1998, is a paramyxovirus that results in severe encephalitis and respiratory disease in infected human beings, with a case fatality rate ranging between 40% and 75%. The disease spreads from infected fruit bats to human beings, either through an intermediate host, such as pigs, or through direct contact with infected bat secretions, thereby becoming a major cause of public health concern in endemic countries such as Bangladesh, India, and Southeast Asia.
The market has attracted significant attention owing to the high potential of the virus to cause a pandemic and its inclusion as a priority pathogen by the WHO, thereby emphasizing the need for R&D. The rising incidence rate of zoonotic disease outbreaks, combined with the increased recognition of biosecurity threats and the improvement in surveillance, is contributing to the continued investment by pharmaceutical companies, biotechnology companies, and public health organizations, thereby creating an innovative market scenario in the case of Nipah virus infection.
Market Dynamics
The global market for Nipah virus infection is influenced by the rising incidence rate of zoonotic infections, the global focus on pandemic preparedness, and the increased government and international funding levels for emerging infectious diseases. The WHO's categorization of the Nipah virus as a priority pathogen is driving the growth of the market, as is the increased funding support from organizations such as the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of vaccines against the Nipah virus.
Moreover, the increased rate of urbanization and deforestation in endemic regions is driving the market, as the increased rate of interaction between animals and humans is elevating the risk of the spread of the infection. The increased rate of technological advancements in the molecular diagnostics market, especially in the case of real-time PCR and next-generation sequencing, is driving the market.
However, the market is also affected by significant restraints, especially because of the sporadic and localized nature of the infection, causing less commercial interest in investment opportunities in the pharmaceutical market. The high cost of development of vaccines and medicines, along with the difficulties encountered while conducting clinical trials, are significant restraints to the market. The lack of healthcare infrastructure is also a significant restraint to the market, especially in endemic areas.
Even though the market is affected by significant restraints, the market is also affected by significant opportunities for partnerships and collaborations, and the trend of biosecurity is significant and is expected to have positive implications for the potential of the market in the future, especially through the use of One Health and rapid vaccine development technologies.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global Nipah virus infection market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include BioPerfectus, Molbio Diagnostics, Huwel Lifesciences, BGI Genomics, ELK Biotechnology, Creative Diagnostics, RayBiotech, Abbexa, AntibodySystem, and Alpha Diagnostic Intl
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global Nipah virus infection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Nipah virus infection market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Assay kits
- Instruments/Analyzers
- Reagents and Consumables
- Test Type Insights (Revenue, USD Mn, 2021 - 2033)
- Molecular Tests
- Serology Tests
- Antigen-Detection Tests
- Confirmatory/Specialized Tests
- Technology Platform Insights (Revenue, USD Mn, 2021 - 2033)
- PCR-Based Testing
- ELISA
- Lateral Flow
- Next-Generation Sequencing
- Others
- Sample Type Insights (Revenue, USD Mn, 2021 - 2033)
- Blood/ Serum
- Urine
- Cerebrospinal Fluid (CSF)
- Throat Swab
- Nasal Swab
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Infectious Disease Centers
- Public Health Agencies
- Reference Laboratories
- Others
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- BioPerfectus
- Molbio Diagnostics
- Huwel Lifesciences
- BGI Genomics
- ELK Biotechnology
- Creative Diagnostics
- RayBiotech
- Abbexa
- AntibodySystem
- Alpha Diagnostic Intl
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Nipah Virus Infection Market, By Product Type
- Global Nipah Virus Infection Market, By Test Type
- Global Nipah Virus Infection Market, By Technology Platform
- Global Nipah Virus Infection Market, By Sample Type
- Global Nipah Virus Infection Market, By End User
- Global Nipah Virus Infection Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Nipah Virus Infection Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Assay kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Instruments/Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Reagents and Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Nipah Virus Infection Market, By Test Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Molecular Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Serology Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Antigen-Detection Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Confirmatory/Specialized Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Nipah Virus Infection Market, By Technology Platform, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- PCR-Based Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- ELISA
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Lateral Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Next-Generation Sequencing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Nipah Virus Infection Market, By Sample Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Blood/ Serum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Urine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cerebrospinal Fluid (CSF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Throat Swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Nasal Swab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Nipah Virus Infection Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Infectious Disease Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Public Health Agencies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Reference Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Nipah Virus Infection Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Sample Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- BioPerfectus
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Molbio Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Huwel Lifesciences
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BGI Genomics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ELK Biotechnology
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Creative Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- RayBiotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbexa
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AntibodySystem
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alpha Diagnostic Intl
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
